Bridging the Gap Between Mouse Behavior and Human Cognition in Neurofibromatosis Type 1

por Payne, Jonathan M.
Publicado 2015

Visual spatial learning outcomes for clinical trials in neurofibromatosis type 1

por Ullrich, Nicole J., Payne, Jonathan M., Walsh, Karin S., Cutter, Gary, Packer, Roger, North, Kathryn, Rey‐Casserly, Celiane
Publicado 2020

Does cannabidiol reduce severe behavioural problems in children with intellectual disability? Study protocol for a pilot single-site phase I/II randomised placebo controlled trial

por Efron, Daryl, Taylor, Kaitlyn, Payne, Jonathan M, Freeman, Jeremy L, Cranswick, Noel, Mulraney, Melissa, Prakash, Chidambaram, Lee, Katherine J, Williams, Katrina
Publicado 2020

A randomized controlled trial of remote microphone listening devices to treat auditory deficits in children with neurofibromatosis type 1

por Rance, Gary, Maier, Alice, Zanin, Julien, Haebich, Kristina M., North, Kathryn N., Orsini, Francesca, Dabscheck, Gabriel, Delatycki, Martin B., Payne, Jonathan M.
Publicado 2022

Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1

por Rance, Gary, Zanin, Julien, Maier, Alice, Chisari, Donella, Haebich, Kristina M., North, Kathryn N., Dabscheck, Gabriel, Seal, Marc L., Delatycki, Martin B., Payne, Jonathan M.
Publicado 2021

Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial

por Pride, Natalie A, Barton, Belinda, Hutchins, Paul, Coghill, David R, Korgaonkar, Mayuresh S, Hearps, Stephen J C, Rouel, Melissa, Malarbi, Stephanie, North, Kathryn N, Payne, Jonathan M
Publicado 2018

Sensory Processing in Children and Adolescents with Neurofibromatosis Type 1

por Pride, Natalie A., Haebich, Kristina M., Walsh, Karin S., Lami, Francesca, Rouel, Melissa, Maier, Alice, Chisholm, Anita K., Lorenzo, Jennifer, Hearps, Stephen J. C., North, Kathryn N., Payne, Jonathan M.
Publicado 2023

Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study

por Haebich, Kristina M, Pride, Natalie A, Walsh, Karin S, Chisholm, Anita, Rouel, Melissa, Maier, Alice, Anderson, Vicki, Barton, Belinda, Silk, Tim, Korgaonkar, Mayuresh, Seal, Marc, Lami, Francesca, Lorenzo, Jennifer, Williams, Katrina, Dabscheck, Gabriel, Rae, Caroline D, Kean, Michael, North, Kathryn N, Payne, Jonathan M
Publicado 2019

Delineating the autistic phenotype in children with neurofibromatosis type 1

por Chisholm, Anita K., Haebich, Kristina M., Pride, Natalie A., Walsh, Karin S., Lami, Francesca, Ure, Alex, Maloof, Tiba, Brignell, Amanda, Rouel, Melissa, Granader, Yael, Maier, Alice, Barton, Belinda, Darke, Hayley, Dabscheck, Gabriel, Anderson, Vicki A., Williams, Katrina, North, Kathryn N., Payne, Jonathan M.
Publicado 2022

Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1

por Payne, Jonathan M., Hearps, Stephen J. C., Walsh, Karin S., Paltin, Iris, Barton, Belinda, Ullrich, Nicole J., Haebich, Kristina M., Coghill, David, Gioia, Gerard A., Cantor, Alan, Cutter, Gary, Tonsgard, James H., Viskochil, David, Rey‐Casserly, Celiane, Schorry, Elizabeth K., Ackerson, Joseph D., Klesse, Laura, Fisher, Michael J., Gutmann, David H., Rosser, Tena, Packer, Roger J., Korf, Bruce, Acosta, Maria T., North, Kathryn N.
Publicado 2019